NIH-funded research R01 grant

Understanding how intestinal T cells keep colorectal cancer in check

Official title: Defining mechanisms of epithelial surveillance by intestinal T cells

Funded at Rockefeller University · NIH-11376706 · Data updated 2026-11-12

Scientists are studying how immune cells in the gut lining help prevent colorectal cancer, especially in cases where current immunotherapies don’t work well.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 1, 2017
Project endJune 30, 2030
Funding year2026
Award (this year)$916,243
NIH project number2R01DK113375-10
Project IDNIH-11376706 on NIH RePORTER

Who could benefit from this research

Could help

Patients with colorectal cancer, especially MSS CRC, could eventually benefit from therapies informed by this work.

Less likely to help

Direct patient benefit may be limited to future therapies; current patients are not enrolled in this grant.

What this research studies

This project explores how specific T cells in the intestinal lining interact with the gut environment to stop early tumor growth. It uses advanced mouse models and tumor organoids to see how T cell recruitment, clonal expansion, and signaling influence cancer control. The work builds on prior findings about gamma-damma T cells and IgA’s role in keeping cell growth in check, aiming to map mechanisms that could be targeted in people. The research team will use genetic fate-mapping tools to trace T cell behavior during tumor development and evaluate how mucosal signals shape surveillance.

Why it matters

Potential benefit: If successful, this research could reveal new targets to boost gut immune surveillance and lead to therapies that help prevent colorectal cancer progression.

How similar studies have gone: Prior studies have shown T cells and IgA influence tumor dynamics, suggesting this approach could yield actionable insights.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Mucida, Daniel S — Rockefeller University
  • Study coordinator: Mucida, Daniel S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.